← Eichor
Study identifier: NCT07549724 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical and Instrumental Assessment Tools for Neurogenic Dysphagia: Translation and Validation

Condition: Dysphagia  ·  Sponsor: IRCCS San Camillo, Venezia, Italy

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

This study aims to translate and validate Italian versions of several clinical assessment tools for patients with neurogenic dysphagia. The instruments include: The New Zealand Secretion Severity Scale, which evaluates secretion management; The Reflex Cough Test from the I\&I cranial nerves assessment; The VASES scale used during fiberoptic endoscopic evaluation of swallowing; The Drooling Severity Scale, which measures saliva control. The study will include approximately 100 patients with neurogenic dysphagia. The goal is to provide reliable, standardized tools in Italian to support clinicians in assessing swallowing and oral-motor function in patients with neurological disorders.

This description comes directly from the study's public registry record.

Talk to the study team

Sara Nordio  ·  3494990310  ·  sara.nordio@hsancamillo.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS San CamilloVenezia, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07549724